Skip To Main Content
Todd Bartkowiak on Muck Rack

Todd Bartkowiak

As seen in: Frontiers, BioRxiv, The Journal of Clinical Investigation, The Journal of Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Todd

Contact Todd, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Volume imaging to interrogate cancer cell-tumor microenvironment interactions in space and time

|
By Marcella Tazzari, Michele Zanoni, Todd Bartkowiak
| Frontiers
Jorge Almagro1 and Hendrik A. Messal2* 1Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, The Rockefeller University, New York, NY, United States 2Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan, Amsterdam, Netherlands Volume imaging visualizes the three-dimensional (3D) complexity of tumors to unravel the dynamic crosstalk between cancer cells and the heterogeneous landscape of the tumor microenvironment (TME).
Open in Who Shared Issue with article?

An immunosuppressed microenvironment distinguishes lateral ventricle-contacting glioblastomas

|
By JCI Insight, Todd Bartkowiak, Sierra Lima, Madeline J. Hayes
| The Journal of Clinical Investigation
ResearchIn-Press PreviewImmunologyOncology Open Access | 10.1172/jci.insight.160652 JCI Insight. https://doi.org/10.1172/jci.insight.160652. Copyright © 2023, Bartkowiak et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Open in Who Shared Issue with article?

Immune desert in MMR-deficient tumors predicts poor responsiveness of immune checkpoint inhibition

|
By Sun Yat-sen, Todd Bartkowiak, Sumit K. Hira, Hend Eltayebi
| Frontiers
Introduction In the past two decades, immunotherapy of cancer has achieved great advances, reflecting the crucial functions of the immune system against cancer progression.
Open in Who Shared Issue with article?
See all 7 articles